The Bellvitge University Hospital has held a pioneering intervention worldwide per extreure a patient rare tumor Located at the tracheal carina, the area on the trachea bifurcates the two main bronchi. This one intervened, considered highly complexhas been made possible thanks to the collaboration of a multidisciplinary team from the public center and the Dr. Diego González Rivas.
According to the hospital, the intervention has been rejected by various medical centers because of the risks it entails. The minimally invasive robotic approach marks a step in the treatment of highly complex tumors.
The patient had a adenoid cystic carcinomaa type of tumor that is rare and resistant to chemo-radiotherapy, for which surgery represents the only curative treatment, explained by this public hospital.
In one conventional surgerythe central location of the tumor requires opening both sides of the thorax to extreure the lung and then connect the trachea to the lung, since the hauria increases the risk of the procedure and prolongs recovery.
A reference in thoracic surgery
The operation is va fer amb robotic technology and with a single incision, a technique in which Dr. González Rivas is a reference in thoracic surgery. One of the main tasks will be to maintain the patient’s oxygenation while the airway was disconnected. The team will use an extracorporeal membrane oxygenation technique (ECMO), a rare method in thoracic surgeries, but essential for this specific type of procedure.
“This operation demonstrates that these complex procedures are possible in the hands of an expert team.”
The minimally invasive approach It will reduce surgical trauma, pain and recovery time for the patient, who has experienced a favorable evolution. “This operation has been a great challenge that demonstrates that the procedures of this complexity are possible in the hands of an expert team,” said Dr. González Rivas in statements collected by the Bellvitge Hospital.
Dr. Amaia Ojanguren, head of the Thoracic Surgery Service, also highlights the relevance of the intervention in thoracic surgery. “This procedure without precedent has been possible thanks to the collaboration of a multidisciplinary team,” he emphasizes in the line item. The operation will take place on October 3 and will involve thoracic surgeons, anesthesiologists, intensive care physicians, pneumolegs, oncologists and specialized nursing staff.
#Pioneering #operation #Bellvitge #hospital #patient #rare #tumor #trachea
